No Impairment of Quality of Life 18 Months After High-Dose Intensity-Modulated Radiotherapy for Localized Prostate Cancer: A Prospective Study

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 4, 2010, Pages 1053-1059

  Marchand, Virginie ^a   Bourdin, Sylvain ^a   Charbonnel, Christelle ^a   Rio, Emmanuel ^a   Munos, Camille ^a   Campion, Loïc ^a   Bonnaud Antignac, Angélique ^b   Lisbona, Albert ^a   Mahé, Marc André ^a   Supiot, Stéphane ^a  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

IMRT; Localized prostate cancer; Predictive factors; Quality of life; Toxicity

Indexed keywords

ADVERSE EFFECT; ADVERSE EVENTS; BOWEL TOXICITY; COMMON TERMINOLOGY CRITERIA; HIGH DOSE; HORMONAL THERAPY; INTENSITY-MODULATED RADIOTHERAPY; LOCALIZED PROSTATE CANCER; PREDICTIVE FACTORS; PROSPECTIVE STUDY; PROSTATE CANCERS; QUALITY OF LIFE; RISK CATEGORIES; URINARY SYMPTOMS;

DOSIMETRY; PHYSICAL THERAPY; RADIOTHERAPY;

TOXICITY;

ANTIANDROGEN; LUTEINIZING HORMONE DERIVATIVE;

ADULT; AGED; ANTIANDROGEN THERAPY; ARTICLE; CANCER FATIGUE; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RISK; CLINICAL ASSESSMENT; COGNITION; DIARRHEA; DISEASE EXACERBATION; DYSPNEA; DYSURIA; EMOTION; FLATULENCE; HEMORRHOID; HEMORRHOID HEMORRHAGE; HUMAN; IMPOTENCE; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; POLLAKISURIA; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; PROSTATE ADENOCARCINOMA; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; SCORING SYSTEM; SOCIAL STATUS; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77953605993     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.024     Document Type: Article

References (42)

1. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
2. D'Amico A.V., Manola J., Loffredo M., et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial. JAMA 292 (2004) 821-827
3. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 360 (2002) 103-106
4. Laverdiere J., Gomez J.L., Cusan L., et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 247-252
5. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
6. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
7. Beckendorf V., Guerif S., Le Prise E., et al. The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1056-1065
8. Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 (2005) 488-498
9. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
10. Ling C.C., Burman C., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 35 (1996) 721-730
11. Chauvet I., Gaboriaud G., Pontvert D., et al. [Constraints and dosage for prostate cancer patients treated with conformal radiotherapy and intensity modulated radiation therapy]. Cancer Radiother 8 (2004) 337-351
12. De Meerleer G.O., Vakaet L.A., De Gersem W.R., et al. Radiotherapy of prostate cancer with or without intensity modulated beams: A planning comparison. Int J Radiat Oncol Biol Phys 47 (2000) 639-648
13. Brabbins D., and Armour E. Clinical validation of the William Beaumont hospital rectal and bladder dose and volume constraint parameters used for 3-D conformal and IMRT prostate radiotherapy planning. Int J Radiat Oncol Biol Phys 54 (2002) 252-253
14. Teh B.S., Woo S.Y., and Butler E.B. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. Oncologist 4 (1999) 433-442
15. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
16. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
17. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 273 (1995) 129-135
18. Smith D.S., Carvalhal G.F., Schneider K., et al. Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer 88 (2000) 1454-1463
19. Wei J.T., Dunn R.L., Litwin M.S., et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56 (2000) 899-905
20. Little D.J., Kuban D.A., Levy L.B., et al. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology 62 (2003) 707-713
21. Litwin M.S., Sadetsky N., Pasta D.J., et al. Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE. J Urol 172 (2004) 515-519
22. Litwin M.S., Flanders S.C., Pasta D.J., et al. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 54 (1999) 503-508
23. Korfage I.J., Essink-Bot M.L., Borsboom G.J., et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 116 (2005) 291-296
24. Sanda M.G., Dunn R.L., Michalski J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358 (2008) 1250-1261
25. Ferrer M., Suarez J.F., Guedea F., et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 421-432
26. Namiki S., Ishidoya S., Tochigi T., et al. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: Comparison with conventional and conformal radiotherapy. Jpn J Clin Oncol 36 (2006) 224-230
27. Lips I., Dehnad H., Kruger A.B., et al. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study. Int J Radiat Oncol Biol Phys 69 (2007) 656-661
28. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
29. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
30. Guren M.G., Dueland S., Skovlund E., et al. Quality of life during radiotherapy for rectal cancer. Eur J Cancer 39 (2003) 587-594
31. Fonteyne V., Villeirs G., Speleers B., et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys 72 (2008) 799-807
32. Lips I.M., Dehnad H., van Gils C.H., et al. High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: Acute and late toxicity in 331 patients. Radiat Oncol 3 (2008) 15
33. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
34. Al-Mamgani A., van Putten W.L., Heemsbergen W.D., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 980-988
35. Su A.W., and Milano M.T. IMRT versus conventional whole pelvis radiotherapy for prostate cancer: Planning comparison and analysis of acute toxicity. Int J Radiat Oncol Biol Phys 63 (2005) S312-S313
36. Mols F., Korfage I.J., Vingerhoets A.J., et al. Bowel, urinary, and sexual problems among long-term prostate cancer survivors: A population-based study. Int J Radiat Oncol Biol Phys 73 (2009) 30-38
37. Kupelian P.A., Reddy C.A., Klein E.A., et al. Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 51 (2001) 988-993
38. Gacci M., Lapini A., Serni S., et al. Predictors of quality of life after radical treatment for prostate cancer. Urol Int 80 (2008) 231-236
39. Pinkawa M., Fischedick K., Asadpour B., et al. Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of bladder volume. Int J Radiat Oncol Biol Phys 64 (2006) 835-841
40. Teh B.S., Dong L., McGary J.E., et al. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim 30 (2005) 25-30
41. de Crevoisier R., Melancon A.D., Kuban D.A., et al. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 1529-1536
42. Wakatsuki M., Tsuji H., Ishikawa H., et al. Quality of life in men treated with carbon ion therapy for prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 1010-1015